Gills and colleagues reported decreased phosphorylation of basal and growth factor activated Akt in response to nelfinavir in lung cancer cells; however, nelfinavir-mediated reduction in Akt phosphorylation was not evident in tumor samples from xenograft models of lung cancer cells. Here, AKT1 is linked to lung carcinoma.